Skip to main content
Erschienen in: Journal of Community Health 1/2018

15.06.2017 | Original Paper

Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians

verfasst von: Laura Donnelly, Kevan M. Sternberg, Takamaru Ashikaga, Mark K. Plante, Scott D. Perrapato

Erschienen in: Journal of Community Health | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to assess the prostate cancer screening practices of Vermont primary care physicians and compare them with a prior study in 2001. An electronic survey was created and emailed to all currently practicing primary care physicians in Vermont. Data was stratified by practice length, practice location, university affiliation, and internal medicine versus family practice. Surveys were received from 123 (27.2%) primary care physicians. 27.7% of physicians in practice <10 years recommended prostate specific antigen (PSA) testing, compared with 55.9% of those practicing ≥10 years (p = 0.006). Of those who modified their recommendations in the past 5 years, 96.1% reported that the United States Preventive Services Task Force (USPSTF) 2012 statement influenced them. Respondents who continued to use PSA testing were less likely to stop screening after age 80 compared with those surveyed in 2001 (51% in 2014 vs. 74% in 2001; p <0.001). Primary care physicians in practice for 10 or more years were more likely to recommend PSA-based screening than those in practice for less time. The USPSTF statement discouraging PSA-based screening for prostate cancer has had significant penetrance among Vermont primary care physicians.
Literatur
1.
Zurück zum Zitat VA Moyer on behalf of the U.S. Preventive Services Task Force (2012). Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 157(2), 120–134.CrossRef VA Moyer on behalf of the U.S. Preventive Services Task Force (2012). Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 157(2), 120–134.CrossRef
2.
Zurück zum Zitat Sarle, R., Zvara, P., Bunnell, M., & Plante, M. (2001). Statewide prostate cancer screening practices among primary care physicians. Preventive Medicine in Managed Care, 2, 137–142. Sarle, R., Zvara, P., Bunnell, M., & Plante, M. (2001). Statewide prostate cancer screening practices among primary care physicians. Preventive Medicine in Managed Care, 2, 137–142.
3.
Zurück zum Zitat Barry, M. J. (2001). Prostate-specific-antigen testing for early diagnosis of prostate cancer. New England Journal of Medicine, 344, 1373–1377.CrossRefPubMed Barry, M. J. (2001). Prostate-specific-antigen testing for early diagnosis of prostate cancer. New England Journal of Medicine, 344, 1373–1377.CrossRefPubMed
4.
Zurück zum Zitat Drazer, M. W., Huo, D., Eggener, S. E. (2015) National Prostate Cancer Screening Rates after the 2012 USPSTF Discouraging PSA-Based Screening. Journal of Clinical Oncology 33(22), 2416–2423.CrossRefPubMed Drazer, M. W., Huo, D., Eggener, S. E. (2015) National Prostate Cancer Screening Rates after the 2012 USPSTF Discouraging PSA-Based Screening. Journal of Clinical Oncology 33(22), 2416–2423.CrossRefPubMed
5.
Zurück zum Zitat Qaseem, A., Barry, M. J., Denberg, T. D., Owens, D. K., & Shekelle, P. (2013). Screening for prostate cancer: A guidance statement from the clinical guidelines Committee of the American College of Physicians. Annals of internal medicine, 158, 761–769.CrossRefPubMed Qaseem, A., Barry, M. J., Denberg, T. D., Owens, D. K., & Shekelle, P. (2013). Screening for prostate cancer: A guidance statement from the clinical guidelines Committee of the American College of Physicians. Annals of internal medicine, 158, 761–769.CrossRefPubMed
9.
Zurück zum Zitat Andriole, G. L., Crawford, E. D., Grubb, R. L., et al. (2009). Mortality results from a randomized prostate-cancer screening trial. The New England Journal of Medicine, 360, 1310–1319.CrossRefPubMedPubMedCentral Andriole, G. L., Crawford, E. D., Grubb, R. L., et al. (2009). Mortality results from a randomized prostate-cancer screening trial. The New England Journal of Medicine, 360, 1310–1319.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Schröder, F. H., Hugosson, J., Roobol, M., et al. (2014). The European randomized study of screening for prostate cancer–prostate cancer mortality at 13 years of follow-up. Lancet, 384(9959), 2027–2035.CrossRefPubMedPubMedCentral Schröder, F. H., Hugosson, J., Roobol, M., et al. (2014). The European randomized study of screening for prostate cancer–prostate cancer mortality at 13 years of follow-up. Lancet, 384(9959), 2027–2035.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Thompson, I. M., Pauler, D. K., Goodman, P. J., et al. (2004). Prevalence of prostate cancer among men with a prostate specific antigen level = < 4.0 ng per milliliter. The New England Journal of Medicine, 350, 2239–2246.CrossRefPubMed Thompson, I. M., Pauler, D. K., Goodman, P. J., et al. (2004). Prevalence of prostate cancer among men with a prostate specific antigen level = < 4.0 ng per milliliter. The New England Journal of Medicine, 350, 2239–2246.CrossRefPubMed
12.
Zurück zum Zitat Bethlehem, J. (2010). Selection bias in web surveys. International Statistical Review, 78(2), 161–188.CrossRef Bethlehem, J. (2010). Selection bias in web surveys. International Statistical Review, 78(2), 161–188.CrossRef
13.
Zurück zum Zitat Miller, A., Yates, J., Epstein, M. M., et al. (2017). Impact of 2012 USPSTF screening psa guideline statement: Changes in primary care provider practice patterns and attitudes. Urology Practice, 4(2), 126–131.CrossRef Miller, A., Yates, J., Epstein, M. M., et al. (2017). Impact of 2012 USPSTF screening psa guideline statement: Changes in primary care provider practice patterns and attitudes. Urology Practice, 4(2), 126–131.CrossRef
Metadaten
Titel
Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians
verfasst von
Laura Donnelly
Kevan M. Sternberg
Takamaru Ashikaga
Mark K. Plante
Scott D. Perrapato
Publikationsdatum
15.06.2017
Verlag
Springer US
Erschienen in
Journal of Community Health / Ausgabe 1/2018
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-017-0384-x

Weitere Artikel der Ausgabe 1/2018

Journal of Community Health 1/2018 Zur Ausgabe